IL1B and breast cancer: In this single-center, prospective, randomized clinical trial, the use of regional anesthesia had no significant effect on changing biomarker levels (69), whereas overall, results from various other studies indicated that a lower level of IL-1β was associated with better breast cancer outcomes.